Morgan Stanley (MS) concluded trading on Wednesday at a closing price of $131.81, with 5.81 million shares of worth about $765.84 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 1.42% during that period and on June 11, 2025 the price saw a loss of about -0.01%. Currently the company’s common shares owned by public are about 1.61B shares, out of which, 1.23B shares are available for trading.
Stock saw a price change of 2.85% in past 5 days and over the past one month there was a price change of 3.74%. Year-to-date (YTD), MS shares are showing a performance of 4.84% which increased to 35.69% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $90.94 but also hit the highest price of $142.03 during that period. The average intraday trading volume for Morgan Stanley shares is 7.21 million. The stock is currently trading 1.80% above its 20-day simple moving average (SMA20), while that difference is up 9.87% for SMA50 and it goes to 8.79% higher than SMA200.
Morgan Stanley (NYSE: MS) currently have 1.61B outstanding shares and institutions hold larger chunk of about 62.45% of that.
The stock has a current market capitalization of $211.47B and its 3Y-monthly beta is at 1.29. PE ratio of stock for trailing 12 months is 15.47, while it has posted earnings per share of $8.52 in the same period. Its PEG reads 1.86 while making debt-to-equity ratio of 3.87. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MS, volatility over the week remained 0.47% while standing at 1.22% over the month.
Stock’s fiscal year EPS is expected to rise by 9.00% while it is estimated to increase by 7.23% in next year. EPS is likely to shrink at an annualized rate of 8.31% for next 5-years, compared to annual growth of 8.89% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Morgan Stanley (MS) stock as an Equal weight in their note to investors on November 15, 2024, suggesting a price target of $142 for the stock. Stock get an Underweight rating from Wells Fargo on August 02, 2024.
